RIPK3 and neoplasm: These reports indicate that necroptosis by the activation of RIPK1/RIPK3/MLKL in the TME can induce APC maturation through the release of DAMPs and promote strong antitumor immunity by inducing tumor-specific CD8+ T-cells.